Vaginal irritation models: The current status of available alternative and in vitro tests

ATLA Alternatives to Laboratory Animals

Volumn 39, Issue 4, 2011, Pages 317-337

  Costin, Gertrude Emilia ^a   Raabe, Hans A ^a   Priston, Robert ^b   Evans, Eric ^b   Curren, Rodger D ^a  

^a IIVS   (United States)

^b KIMBERLY CLARK CORPORATION   (United States)

Author keywords

Alternatives to animal testing; In vitro assays; Vaginal irritation

Indexed keywords

MICROBICIDE; SPERMICIDAL AGENT;

ANIMAL EXPERIMENT; CELL CULTURE; CLINICAL ASSESSMENT; DISEASE MODEL; DISEASE PREDISPOSITION; DRUG DELIVERY SYSTEM; EXPERIMENTAL MONKEY; EXPERIMENTAL MOUSE; EXPERIMENTAL PIG; EXPERIMENTAL RABBIT; EXPERIMENTAL RAT; EXPLANT; HUMAN; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TISSUE STRUCTURE; TOXICITY TESTING; VAGINA DISEASE; VAGINA EPITHELIUM; VAGINAL IRRITATION; VALIDATION PROCESS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 80053394340     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119291103900403     Document Type: Review

References (88)

1. van Damme, L., Ramjee, G., Alary, M., Vuylsteke, B., Chandeying, V., Rees, H., Sirivongrangson, P., Mukenge-Tshibaka, L., Ettiegne-Traore, V., Uaheowitchai, C., Karim, S.S., Masse, B., Perriens, J. & Laga, M. (2002). Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: A randomised controlled trial. Lancet 360, 971-977. (Pubitemid 35284107)
2. Center for Drug Evaluation and Research (1995). Guidance for Industry. Guidance for Development of Vaginal Contraceptive Drugs, 6pp. Silver Spring, MD, USA: US Department of Health and Human Services, Food and Drug Administration. Available at: http://www.fda.gov/downloads/ScienceResearch/SpecialTopics/ WomensHealthResearch/UCM131211.pdf (Accessed 22.06.11).
3. Anon. (2009). Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products (recast). Official Journal of the European Union L342, 22.12. 2009, 59-209.
4. Cotovio, J., Grandidier, M.H., Portes, P., Roguet, R. & Rubinstenn, G. (2005). The in vitro skin irritation of chemicals: Optimisation of the EPISKIN prediction model within the framework of the ECVAM validation process. ATLA 33, 329-349. (Pubitemid 41330270)
5. Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J.H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandarova, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. & Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. ATLA 35, 559-601. (Pubitemid 351169735)
6. SkinEthic Laboratories (2009). SkinEthic Skin Irritation Test-42bis. Standard Operating Procedure (SOP), 43pp. Nice, France: SkinEthic laboratories. Available at: http://ecvam.jrc.it/ft-doc/SkinEthic-RHE-SOP%20INVITTOX%202.0.pdf (Accessed 22. 06.11).
7. MatTek Corporation (2009). Protocol for In Vitro EpidermTM Skin Irritation Test (EPI-200-SIT), 37pp. Ashland, MA, USA: MatTek Corporation. Available at: http://ecvam.jrc.it/ft-doc/MK-24-007- 0023%20Modified%20EpiDerm%20SIT-SOP%202009-03-23.pdf (Accessed 22.06.11).
8. Alexander, N.J., Baker, E., Kaptein, M., Karck, U., Miller, L. & Zampaglione, E. (2004). Why consider vaginal drug administration? Fertility & Sterility 82, 1-12. (Pubitemid 38968766)
9. Justin-Temu, M., Damian, F., Kinget, R. & van Den Mooter, G. (2004). Intravaginal gels as drug delivery systems. Journal of Women's Health 13, 834-844. (Pubitemid 39369265)
10. Hussain, A. & Ahsan, F. (2005). The vagina as a route for systemic drug delivery. Journal of Controlled Release 103, 301-313. (Pubitemid 40342532)
11. Uckun, F.M. & D'Cruz, O.J. (1999). Prophylactic contraceptives for HIV/AIDS. Human Reproduction Update 5, 506-514. (Pubitemid 29512137)
12. Niruthisard, S., Roddy, R.E. & Chutivongse, S. (1991). The effects of frequent nonoxynol-9 use on the vaginal and cervical mucosa. Sexually Transmitted Diseases 18, 176-179.
13. Roddy, R.E., Cordero, M., Cordero, C. & Fortney, J.A. (1993). A dosing study of nonoxynol-9 and genital irritation. International Journal of STD & AIDS 4, 165-170. (Pubitemid 23161760)
14. Stafford, M.K., Ward, H., Flanagan, A., Rosenstein, I.J., Taylor-Robinson, D., Smith, J.R., Weber, J. & Kitchen, V.S. (1998). Safety study of nonoxynol-9 as a vaginal microbicide: Evidence of adverse effects. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 17, 327-331.
15. Hooton, T.M., Hillier, S., Johnson, C., Roberts, P.L. & Stamm, W.E. (1991). Escherichia coli bacteriuria and contraceptive method. Journal of the American Medical Association 265, 64-69.
16. Rosenstein, I.J., Stafford, M.K., Kitchen, V.S., Ward, H., Weber, J.N. & Taylor-Robinson, D. (1998). Effect on normal vaginal flora of three intravaginal microbicidal agents potentially active against human immunodeficiency virus type 1. Journal of Infectious Diseases 177, 1386-1390. (Pubitemid 28194284)
17. Fichorova, R.N., Tucker, L.D. & Anderson, D.J. (2001). The molecular basis of nonoxynol-9-induced vaginal inflammation and its possible relevance to human immunodeficiency virus type 1 transmission. Journal of Infectious Diseases 184, 418-428. (Pubitemid 32718505)
18. Achilles, S.L., Shete, P.B., Whaley, K.J., Moench, T.R. & Cone, R.A. (2002). Microbicide efficacy and toxicity tests in a mouse model for vaginal transmission of Chlamydia trachomatis. Sexually Transmitted Diseases 29, 655-664. (Pubitemid 35266407)
19. D'Cruz, O.J. & Uckun, F.M. (2002). Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07). Journal of Antimicrobial Chemotherapy 50, 793-803. (Pubitemid 36032797)
20. Holzaepfel, J.H., Warner, J.S., Buxton, J.A. & Howard, J.A. (1958). Sensitivity to vaginal jellies: Correlation between clinical tests and animal tests. Journal of the American Pharmaceutical Association 47, 423-425.
21. Eckstein, P. (1959). Harmlessness tests of chemical contraceptives in rhesus monkeys. In Proceedings of the 6th International Conference Planned Parenthood, New Delhi, p. 620. London, UK: International Planned Parenthood Federation.
22. Eckstein, P., Jackson, M.C., Millman, N. & Sobrero, A.J. (1969). Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys. Journal of Reproduction & Fertility 20, 85-93.
23. Patton, D.L., Kidder, G.G., Sweeney, Y.C., Rabe, L.K. & Hillier, S.L. (1999). Effects of multiple applications of benzalkonium chloride and nonoxynol 9 on the vaginal epithelium in the pigtailed macaque (Macaca nemestrina). American Journal of Obstetrics & Gynecology 180, 1080-1087. (Pubitemid 29258998)
24. D'Cruz, O.J., Erbeck, D. & Uckun, F.M. (2005). A study of the potential of the pig as a model for the vaginal irritancy of benzalkonium chloride in comparison to the nonirritant microbicide PHI-443 and the spermicide vanadocene dithiocarbamate. Toxicol ogic Pathology 33, 465-476. (Pubitemid 40995486)
25. Carleton, H.M. & Florey, H. (1931). Birth control studies. 2. Observation on the effects of common contraceptives on the vaginal and uterine mucosa. Journal of Obstetrics & Gynaecology of the British Empire 38, 555.
26. Chvapil, M., Droegemueller, W., Owen, J.A., Eskelson, C.D. & Betts, K. (1980). Studies of nonoxynol-9. I. The effect on the vaginas of rabbits and rats. Fertility & Sterility 33, 445-450. (Pubitemid 10110411)
27. Kaminsky, M. & Willigan, D.A. (1982). pH and the potential irritancy of douche formulations to the vaginal mucosa of the albino rabbit and rat. Food & Chemical Toxicology 20, 193-196. (Pubitemid 12058513)
28. Kaminsky, M., Szivos, M.M., Brown, K.R. & Willigan, D.A. (1985). Comparison of the sensitivity of the vaginal mucous membranes of the albino rabbit and laboratory rat to nonoxynol-9. Food & Chemical Toxicology 23, 705-708. (Pubitemid 16240193)
29. Adriaens, E. & Remon, J.P. (2002). Evaluation of an alternative mucosal irritation test using slugs. Toxicology & Applied Pharmacology 182, 169-175. (Pubitemid 34971721)
30. Dhondt, M.M., Adriaens, E. & Remon, J.P. (2004). The evaluation of the local tolerance of vaginal formulations, with or without nonoxynol-9, using the slug mucosal irritation test. Sexually Transmitted Diseases 31, 229-235. (Pubitemid 38401921)
31. ISO (1995). ISO 10993-10 Standard Biological Evaluation of Medical Devices, Part 10 - Tests for Irritation and Sensitization, Annex D, pp. 20-26. Geneva, Switzerland: International Organization for Standardization.
32. Noguchi, K., Tsukumi, K. & Urano, T. (2003). Qualitative and quantitative differences in normal vaginal flora of conventionally reared mice, rats, hamsters, rabbits, and dogs. Comparative Medicine 53, 404-412. (Pubitemid 37129300)
33. Zaneveld, L.J., Waller, D.P., Ahmad, N., Quigg, K., Kaminski, J., Nikurs, A. & De Jonge, C. (2001). Properties of a new, long-lasting vaginal delivery system (LASRS) for contraceptive and antimicrobial agents. Journal of Andrology 22, 481-490. (Pubitemid 32322140)
34. Promadej-Lanier, N., Smith, J.M., Srinivasan, P., McCoy, C.F., Butera, S., Woolfson, A.D., Malcolm, R.K. & Otten, R.A. (2009). Development and evaluation of a vaginal ring device for sustained delivery of HIV microbicides to non-human primates. Journal of Medical Primatology 38, 263-271.
35. Hunter, R.H. (1975). Physiological aspects of sperm transport in the domestic pig, Sus scrofa. II. Regulation, survival and fate of cells. British Veterinary Journal 131, 681-690.
36. Hunter, R.H. (1977). Physiological factors influencing ovulation, fertilization, early embryonic development and establishment of pregnancy in pigs. British Veterinary Journal 133, 461-470.
37. Pond, W.G. & Houpt, K.A. (1988). Reproductive phys iology. In The Biology of the Pig (ed. W. Pond & K. Houpt), pp. 129-180. New York, NY, USA: Cornell University Press.
38. Cole, D.J.A. & Foxcroft, G.R. (1982). Control of Pig Reproduction, 676pp. London, UK: Butterworth Scientific.
39. Catalone, B.J., Kish-Catalone, T.M., Budgeon, L.R., Neely, E.B., Ferguson, M., Krebs, F.C., Howett, M.K., Labib, M., Rando, R. & Wigdahl, B. (2004). Mouse model of cervicovaginal toxicity and inflammation for preclinical evaluation of topical vaginal microbicides. Antimicrobial Agents & Chemotherapy 48, 1837-1847. (Pubitemid 38544396)
40. Neyts, J., Kristmundsdottir, T., De Clercq, E. & Thormar, H. (2000). Hydrogels containing monocaprin prevent intravaginal and intracutaneous infections with HSV-2 in mice: Impact on the search for vaginal microbicides. Journal of Medical Virology 61, 107-110. (Pubitemid 30191234)
41. D'Cruz, O.J. & Uckun, F.M. (2001). Gel-microemulsions as vaginal spermicides and intravaginal drug delivery vehicles. Contraception 64, 113-123. (Pubitemid 33042598)
42. D'Cruz, O.J., Yiv, S.H., Waurzyniak, B. & Uckun, F.M. (2001). Contraceptive efficacy and safety studies of a novel microemulsion-based lipophilic vaginal spermicide. Fertility & Sterility 75, 115-124. (Pubitemid 32041232)
43. Kish-Catalone, T.M., Lu, W., Gallo, R.C. & DeVico, A.L. (2006). Preclinical evaluation of synthetic-2 RANTES as a candidate vaginal microbicide to target CCR5. Antimicrobial Agents & Chemotherapy 50, 1497-1509.
44. Davis, B.J., Traylos, G. & McShane, T. (2001). Reproductive endocrinology and toxicological pathology over the life span of the female rodent. Toxicologic Pathology 29, 77-83. (Pubitemid 32127325)
45. Adriaens, E. (2006). The Slug Mucosal Irritation Assay: An Alternative Assay for Local Tolerance Testing, 9pp. London, UK: National Centre for the Replacement, Refinement and Reduction of Animals in Research.
46. Adriaens, E. & Remon, J.P. (1999). Gastropods as an evaluation tool for screening the irritating potency of absorption enhancers and drugs. Pharmaceutical Research 16, 1240-1244. (Pubitemid 29393613)
47. Adriaens, E., Dierckens, K., Bauters, T.G., Nelis, H.J., van Goethem, F., vanparys, P. & Remon, J.P. (2001). The mucosal toxicity of different benzalkonium chloride analogues evaluated with an alternative test using slugs. Pharmaceutical Research 18, 937-942. (Pubitemid 32799937)
48. Ceulemans, J., Vermeire, A., Adriaens, E., Remon, J.P. & Ludwig, A. (2001). Evaluation of a mucoadhesive tablet for ocular use. Journal of Controlled Release 77, 333-344. (Pubitemid 33145484)
49. Adriaens, E., Ameye, D., Dhondt, M.M., Foreman, P. & Remon, J.P. (2003). Evaluation of the mucosal irritation potency of co-spray dried Amioca/poly(acrylic acid) and Amioca/Carbopol 974P mixtures. Journal of Controlled Release 88, 393-399. (Pubitemid 36331881)
50. Weyenberg, W., Vermeire, A., Dhondt, M.M., Adriaens, E., Kestelyn, P., Remon, J.P. & Ludwig, A. (2004). Ocular bioerodible minitablets as strategy for the management of microbial keratitis. Investigative Opthalmology & Visual Science 45, 3229-3233. (Pubitemid 39121860)
51. Dhondt, M.M., Adriaens, E., Roey, J.V. & Remon, J.P. (2005). The evaluation of the local tolerance of vaginal formulations containing dapivirine using the Slug Mucosal Irritation test and the Rabbit Vaginal Irritation test. European Journal of Pharmaceutics & Biopharmaceutics 60, 419-425. (Pubitemid 40922840)
52. Martin, H.L., Jr, Stevens, C.E., Richardson, B.A., Rugamba, D., Nyange, P.M., Mandaliya, K., Ndinya-Achola, J. & Kreiss, J.K. (1997). Safety of a nonoxynol-9 vaginal gel in Kenyan prostitutes: A randomized clinical trial. Sexually Transmitted Diseases 24, 279-283. (Pubitemid 27208979)
53. Mayer, K.H., Peipert, J., Fleming, T., Fullem, A., Moench, T., Cu-Uvin, S., Bentley, M., Chesney, M. & Rosenberg, Z. (2001). Safety and tolerability of BufferGel, a novel vaginal microbicide, in women in the United States. Clinical Infectious Diseases 32, 476-482. (Pubitemid 32173636)
54. van de Wijgert, J.H., Kilmarx, P.H., Jones, H.E., Karon, J.M. & Chaikummao, S. (2008). Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials. Cont raception 77, 122-129.
55. Sobel, J.D., Tchao, R., Bozzola, J., Levison, M.E. & Kaye, D. (1979). Human vaginal epithelial multilayer tissue culture. In Vitro 15, 993-1000. (Pubitemid 10121934)
56. Krebs, F.C., Miller, S.R., Catalone, B.J., Welsh, P.A., Malamud, D., Howett, M.K. & Wigdahl, B. (2000). Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: Comparative sensitivity of primary human vaginal keratinocytes. Antimicrobial Agents & Chemotherapy 44, 1954-1960. (Pubitemid 30422954)
57. Rajan, N., Pruden, D.L., Kaznari, H., Cao, Q., Anderson, B.E., Duncan, J.L. & Schaeffer, A.J. (2000). Characterization of an immortalized human vaginal epithelial cell line. Journal of Urology 163, 616-622. (Pubitemid 30060536)
58. Fichorova, R.N., Rheinwald, J.G. & Anderson, D.J. (1997). Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins. Biology of Reproduction 57, 847-855. (Pubitemid 27407205)
59. Fichorova, R.N., Bajpai, M., Chandra, N., Hsiu, J.G., Spangler, M., Ratnam, V. & Doncel, G.F. (2004). Interleukin (IL)-1, IL-6, and IL-8 predict mucosal toxicity of vaginal microbicidal contraceptives. Biology of Reproduction 71, 761-769. (Pubitemid 39108635)
60. Krebs, F.C., Miller, S.R., Catalone, B.J., Fichorova, R., Anderson, D., Malamud, D., Howett, M.K. & Wigdahl, B. (2002). Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate. Antimicrobial Agents & Chemotherapy 46, 2292-2298. (Pubitemid 34665935)
61. OECD (2009). OECD Guideline for the Testing of Chemicals. Draft Proposal for a New Guideline. In Vitro Skin Irritation: Reconstructed Human Epidermis (RhE) Test Method, 19pp. Paris, France: Organisation for Economic Co-operation and Development. Available at: http://www.oecd.org/dataoecd/1/59/43664841.pdf (Accessed 22.06.11).
62. Sivard, P., Berlier, W., Picard, B., Sabido, O., Genin, C. & Misery, L. (2004). HIV-1 infection of Langerhans cells in a reconstructed vaginal mucosa. Journal of Infectious Diseases 190, 227-235. (Pubitemid 38951960)
63. Cremel, M., Berlier, W., Hamzek, H., Cognasse, F., Lawrence, P., Genin, C., Bernengo, J.C., Lambert, C., Dieu-Nosjean, M.C. & Delezay, O. (2005). Characterization of CCL20 secretion by human epithelial vaginal cells: Involvement in Langerhans cell precursor attraction. Journal of Leukocyte Biology 78, 158-166. (Pubitemid 40979954)
64. Morris, H.H., Gatter, K.C., Stein, H. & Mason, D.Y. (1983). Langerhans' cells in human cervical epithelium: An immunohistological study. British Journal of Obstetrics & Gynaecology 90, 400-411. (Pubitemid 13096208)
65. Bouschbacher, M., Bomsel, M., Verronese, E., Gofflo, S., Ganor, Y., Dezutter-Dambuyant, C. & Valladeau, J. (2008). Early events in HIV transmission through a human reconstructed vaginal mucosa. AIDS 22, 1257-1266.
66. Hjelm, B.E., Berta, A.N., Nickerson, C.A., Arntzen, C.J. & Herbst-Kralovetz, M.M. (2010). Development and characterization of a three-dimensional organotypic human vaginal epithelial cell model. Biology of Reproduction 82, 617-627.
67. Ayehunie, S., Cannon, C., Lamore, S., Kubilus, J., Anderson, D.J., Pudney, J. & Klausner, M. (2006). Organotypic human vaginal-ectocervical tissue model for irritation studies of spermicides, microbicides, and feminine-care products. Toxicology in Vitro 20, 689-698. (Pubitemid 43816250)
68. Canny, G.O., Trifonova, R.T., Kindelberger, D.W., Colgan, S.P. & Fichorova, R.N. (2006). Expression and function of bactericidal/permeability- increasing protein in human genital tract epithelial cells. Journal of Infectious Diseases 194, 498-502. (Pubitemid 44162662)
69. Fichorova, R.N., Trifonova, R.T., Gilbert, R.O., Costello, C.E., Hayes, G.R., Lucas, J.J. & Singh, B.N. (2006). Trichomonas vaginalis lipophosphoglycan triggers a selective upregulation of cytokines by human female reproductive tract epithelial cells. Infection & Immunity 74, 5773-5779. (Pubitemid 44484563)
70. Trifonova, R.T., Pasicznyk, J.M. & Fichorova, R.N. (2006). Biocompatibility of solid-dosage forms of antihuman immunodeficiency virus type 1 microbicides with the human cervicovaginal mucosa modeled ex vivo. Antimicrobial Agents & Chemotherapy 50, 4005-4010. (Pubitemid 44865142)
71. Ayehunie, S., Cannon, C., Larosa, K., Pudney, J., Anderson, D.J. & Klausner, M. (2011). Development of an in vitro alternative assay method for vaginal irritation. Toxicology 279, 130-138.
72. Schaller, M., Bein, M., Korting, H.C., Baur, S., Hamm, G., Monod, M., Beinhauer, S. & Hube, B. (2003). The secreted aspartyl proteinases Sap1 and Sap2 cause tissue damage in an in vitro model of vaginal reconstituted human vaginal epithelium. Infection & Immunity 71, 3227-3234. (Pubitemid 36637547)
73. Schaller, M., Korting, H.C., Borelli, C., Hamm, G. & Hube, B. (2005). Candida albicans-secreted aspartic proteinases modify the epithelial cytokine response in an in vitro model of vaginal candidiasis. Infection & Immunity 73, 2758-2765. (Pubitemid 40570342)
74. Hu, Q., Frank, I., Williams, V., Santos, J.J., Watts, P., Griffin, G.E., Moore, J.P., Pope, M. & Shattock, R.J. (2004). Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. Journal of Experimental Medicine 8, 1065-1075. (Pubitemid 38619903)
75. Richardson-Harman, N., Lackman-Smith, C., Fletcher, P.S., Anton, P.A., Bremer, J.W., Dezzutti, C.S., Elliott, J., Grivel, J.C., Guenthner, P., Gupta, P., Jones, M., Lurain, N.S., Margolis, L.B., Mohan, S., Ratner, D., Reichelderfer, P., Roberts, P., Shattock, R.J. & Cummins, J.E., Jr (2009). Multisite comparison of anti-human immunodeficiency virus microbicide activity in explant assays using a novel endpoint analysis. Journal of Clinical Microbiology 47, 3530-3539.
76. Cummins, J.E., Jr, Guarner, J., Flowers, L., Guenthner, P.C., Bartlett, J., Morken, T., Grohskopf, L.A., Paxton, L. & Dezzutti, C.S. (2007). Preclinical testing of candidate topical microbicides for anti-human immunodeficiency virus type 1 activity and tissue toxicity in a human cervical explant culture. Antimicrobial Agents & Chemotherapy 51, 1770-1779. (Pubitemid 46744157)
77. Gupta, P., Ratner, D., Patterson, B.K., Kulka, K., Rohan, L.C., Parniak, M.A., Isaacs, C.E. & Hillier, S. (2006). Use of frozen-thawed cervical tissues in the organ culture system to measure anti-HIV activities of candidate microbicides. AIDS Research & Human Retroviruses 22, 419-424. (Pubitemid 43787766)
78. Anderson, D.J., Pudney, J. & Schust, D.J. (2010). Caveats associated with the use of human cervical tissue for HIV and microbicide research. AIDS 24, 1-4.
79. Squier, C.A., Mantz, M.J., Schlievert, P.M. & Davis, C.C. (2008). Porcine vagina ex vivo as a model for studying permeability and pathogenesis in mucosa. Journal of Pharmaceutical Sciences 97, 9-21.
80. van der Bijl, P., Thompson, I.O. & Squier, C.A. (1997). Comparative permeability of human vaginal and buccal mucosa to water. European Journal of Oral Sciences 105, 571-575. (Pubitemid 127760549)
81. Thompson, I.O., van der Bijl, P., van Wyk, C.W. & van Eyk, A.D. (2001). A comparative light-microscopic, electron-microscopic and chemical study of human vaginal and buccal epithelium. Archives of Oral Biology 46, 1091-1098. (Pubitemid 33086338)
82. van Eyk, A.D. & van den Bijl, P. (2005). Porcine vaginal mucosa as an in vitro permeability model for human vaginal mucosa. International Journal of Pharmaceutics 305, 105-111.
83. Beer, B.E., Doncel, G.F., Krebs, F.C., Shattock, R.J., Fletcher, P.S., Buckheit, R.W., Jr. Watson, K., Dezzutti, C.S., Cummins, J.E., Bromley, E., Richardson-Harman, N., Pallansch, L.A., Lackman-Smith, C., Osterling, C., Mankowski, M., Miller, S.R., Catalone, B.J., Welsh, P.A., Howett, M.K., Wigdahl, B., Turpin, J.A. & Reichelderfer, P. (2006). In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicides: A retrospective analysis of results from five laboratories. Antimicrobial Agents & Chemotherapy 50, 713-723. (Pubitemid 43190987)
84. Garg, S., Taluja, V., Upadhyay, S.N. & Talwar, G.P. (1993). Studies on the contraceptive efficacy of Praneem polyherbal cream. Contraception 48, 591-596. (Pubitemid 24029757)
85. Poindexter, A.N., 3rd, Levine, H., Sangi-Haghpeykar, H., Frank, M.L., Grear, A. & Reeves, K.O. (1996). Comparison of spermicides on vulvar, vaginal, and cervical mucosa. Contraception 53, 147-153. (Pubitemid 26084358)
86. Poonia, B., Walter, L., Dufour, J., Harrison, R., Marx, P.A. & Veazey, R.S. (2006). Cyclic changes in the vaginal epithelium of normal rhesus macaques. Journal of Endocrinology 190, 829-835. (Pubitemid 44560256)
87. Brosnahan, A.J., Mantz, M.J., Squier, C.A., Peterson, M.L. & Schlievert, P.M. (2009). Cytolysins augment superantigen penetration of stratified mucosa. Journal of Immunology 182, 2364-2373.
88. Catalone, B.J., Kish-Catalone, T.M., Neely, E.B., Budgeon, L.R., Ferguson, M.L., Stiller, C., Miller, S.R., Malamud, D., Krebs, F.C., Howett, M.K. & Wigdahl, B. (2005). Comparative safety evaluation of the candidate vaginal microbicide C31G. Antimicrobial Agents & Chemotherapy 49, 1509-1520. (Pubitemid 40463383)